{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T20:45:06Z","timestamp":1792701906018,"version":"4.5.0"},"reference-count":175,"publisher":"MDPI AG","issue":"13","license":[{"start":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T00:00:00Z","timestamp":1782432000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001691","name":"JSPS KAKENHI","doi-asserted-by":"publisher","award":["25K11785"],"award-info":[{"award-number":["25K11785"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"award":["25K11785"],"award-info":[{"award-number":["25K11785"]}],"id":[{"id":"https:\/\/ror.org\/00hhkn466","id-type":"ROR","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004088","name":"Kowa Life Science Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100004088","id-type":"DOI","asserted-by":"crossref"}]},{"id":[{"id":"https:\/\/ror.org\/04jpf9990","id-type":"ROR","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007434","name":"Suzuken Memorial Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100007434","id-type":"DOI","asserted-by":"crossref"}]},{"id":[{"id":"https:\/\/ror.org\/04vs2x012","id-type":"ROR","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008731","name":"Nakatomi Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100008731","id-type":"DOI","asserted-by":"crossref"}]},{"id":[{"id":"https:\/\/ror.org\/0196vdc40","id-type":"ROR","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007664","name":"Manpei Suzuki Diabetes Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100007664","id-type":"DOI","asserted-by":"crossref"}]},{"id":[{"id":"https:\/\/ror.org\/03pkewe16","id-type":"ROR","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007449","name":"Takeda Science Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100007449","id-type":"DOI","asserted-by":"crossref"}]},{"id":[{"id":"https:\/\/ror.org\/02y123g31","id-type":"ROR","asserted-by":"publisher"}]},{"name":"Mochida Memorial Foundation for Medical and Pharmaceutical"},{"id":[{"id":"https:\/\/ror.org\/050rsje66","id-type":"ROR","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003837","name":"Ichiro Kanehara Foundation for the Promotion of Medical Sciences and Medical Care","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100003837","id-type":"DOI","asserted-by":"crossref"}]},{"id":[{"id":"https:\/\/ror.org\/043s0fn12","id-type":"ROR","asserted-by":"publisher"}]},{"name":"Daiwa Securities Foundation"},{"id":[{"id":"https:\/\/ror.org\/007pxvx88","id-type":"ROR","asserted-by":"publisher"}]},{"name":"Kao Health Science Research Society"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biology"],"abstract":"<jats:p>Progression to fibrosis is a major complication of chronic kidney disease (CKD) in obesity, type 2 diabetes, hypertension, and metabolic syndrome, yet effective antifibrotic therapies remain limited. Here, we review how disordered renal energy metabolism\u2014ectopic lipid accumulation, impaired fatty acid oxidation (FAO), and a compensatory shift toward glycolysis\u2014drives tubulointerstitial fibrosis in fatty kidney disease. Lipid overload in tubular, glomerular, and vascular cells arises from increased uptake via scavenger and lipoprotein receptors, enhanced lipogenesis, and reduced lipid catabolism and clearance. Spatial lipidomic studies further reveal nephron-segment-specific lipid signatures and obesity-associated oxidized phospholipids linked to glomerular inflammation. Lipotoxicity, mitochondrial damage, and associated innate-immune signaling, ferroptosis, cellular senescence, and adipose-derived mediators (including leptin, adiponectin, and a locally active renin\u2013angiotensin system) converge on myofibroblast activation from pericytes, fibroblasts, and other resident cells. We discuss established and emerging therapies targeting this metabolic axis\u2014peroxisome proliferator-activated receptor-\u03b1 (PPAR\u03b1) modulators, sodium\u2013glucose cotransporter-2 (SGLT2) inhibitors, glucagon-like peptide-1 (GLP-1) receptor agonists, and the mineralocorticoid receptor antagonist finerenone\u2014and propose that restoring metabolic flexibility, by rescuing FAO while limiting maladaptive glycolysis, offers a promising disease-modifying strategy for fatty kidney disease.<\/jats:p>","DOI":"10.3390\/biology15131021","type":"journal-article","created":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T00:54:42Z","timestamp":1782694482000},"page":"1021","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Fatty Kidney Disease: From Renal Lipid Dysregulation to Fibrosis"],"prefix":"10.3390","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4439-0077","authenticated-orcid":false,"given":"Toshiharu","family":"Onodera","sequence":"first","affiliation":[{"name":"Department of Metabolic Medicine, Graduate School of Medicine, The University of Osaka, Yamadaoka, Suita 565-0871, Osaka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoki","family":"Morimoto","sequence":"additional","affiliation":[{"name":"Department of Metabolic Medicine, Graduate School of Medicine, The University of Osaka, Yamadaoka, Suita 565-0871, Osaka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yosuke","family":"Okuno","sequence":"additional","affiliation":[{"name":"Department of Metabolic Medicine, Graduate School of Medicine, The University of Osaka, Yamadaoka, Suita 565-0871, Osaka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iichiro","family":"Shimomura","sequence":"additional","affiliation":[{"name":"Department of Metabolic Medicine, Graduate School of Medicine, The University of Osaka, Yamadaoka, Suita 565-0871, Osaka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,6,26]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"21","DOI":"10.7326\/0003-4819-144-1-200601030-00006","article-title":"Body Mass Index and Risk for End-Stage Renal Disease","volume":"144","author":"Hsu","year":"2006","journal-title":"Ann. Intern. Med."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"e10022","DOI":"10.1590\/1414-431x202010022","article-title":"Obesity as a Predictive Factor for Chronic Kidney Disease in Adults: Systematic Review and Meta-Analysis","volume":"54","author":"Pinto","year":"2021","journal-title":"Braz. J. Med. Biol. Res."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1038\/s41581-025-00946-1","article-title":"Imaging and Spatially Resolved Mass Spectrometry Applications in Nephrology","volume":"21","author":"Gorman","year":"2025","journal-title":"Nat. Rev. Nephrol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1194\/jlr.P040501","article-title":"Altered Renal Lipid Metabolism and Renal Lipid Accumulation in Human Diabetic Nephropathy","volume":"55","author":"Scherzer","year":"2014","journal-title":"J. Lipid Res."},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Schelling, J.R. (2022). The Contribution of Lipotoxicity to Diabetic Kidney Disease. Cells, 11.","DOI":"10.3390\/cells11203236"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1038\/s41419-024-06833-0","article-title":"Mitochondrial Metabolic Reprogramming in Diabetic Kidney Disease","volume":"15","author":"Fan","year":"2024","journal-title":"Cell Death Dis."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.cmet.2017.01.004","article-title":"Reducing VEGF-B Signaling Ameliorates Renal Lipotoxicity and Protects against Diabetic Kidney Disease","volume":"25","author":"Falkevall","year":"2017","journal-title":"Cell Metab."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"F1871","DOI":"10.1152\/ajprenal.00013.2008","article-title":"CD36 Is One of Important Receptors Promoting Renal Tubular Injury by Advanced Oxidation Protein Products","volume":"295","author":"Iwao","year":"2008","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1016\/j.kint.2016.06.013","article-title":"Protection of Mitochondria Prevents High-Fat Diet\u2013Induced Glomerulopathy and Proximal Tubular Injury","volume":"90","author":"Szeto","year":"2016","journal-title":"Kidney Int."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"4762","DOI":"10.7150\/ijbs.114907","article-title":"Mesangial Cells in Diabetic Kidney Disease: From Mechanisms to Therapeutic Implications","volume":"21","author":"Feng","year":"2025","journal-title":"Int. J. Biol. Sci."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"854","DOI":"10.4158\/EP-2018-0568","article-title":"Fatty Kidney Disease: A New Renal And Endocrine Clinical Entity? Describing the Role of the Kidney in Obesity, Metabolic Syndrome, and Type 2 Diabetes","volume":"25","author":"Mende","year":"2019","journal-title":"Endocr. Pract."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1046\/j.1523-1755.2001.0590041498.x","article-title":"Obesity-Related Glomerulopathy: An Emerging Epidemic","volume":"59","author":"Kambham","year":"2001","journal-title":"Kidney Int."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.kint.2025.01.044","article-title":"Metabolic Dysfunction\u2013Associated Kidney Disease: Pathogenesis and Clinical Manifestations","volume":"108","author":"Bansal","year":"2025","journal-title":"Kidney Int."},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Raphael, H., Klang, E., Konen, E., Inbar, Y., Leibowitz, A., Frenkel-Nir, Y., Apter, S., and Grossman, E. (2024). Obesity Is Associated with Fatty Liver and Fat Changes in the Kidneys in Humans as Assessed by MRI. Nutrients, 16.","DOI":"10.3390\/nu16091387"},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Opazo-R\u00edos, L., Mas, S., Mar\u00edn-Royo, G., Mezzano, S., G\u00f3mez-Guerrero, C., Moreno, J.A., and Egido, J. (2020). Lipotoxicity and Diabetic Nephropathy: Novel Mechanistic Insights and Therapeutic Opportunities. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21072632"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1161\/HYPERTENSIONAHA.111.175315","article-title":"Fatty Kidney, Hypertension, and Chronic Kidney Disease: The Framingham Heart Study","volume":"58","author":"Foster","year":"2011","journal-title":"Hypertension"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1161\/HYPERTENSIONAHA.110.158535","article-title":"Renal Sinus Adiposity and Hypertension","volume":"56","author":"Mazairac","year":"2010","journal-title":"Hypertension"},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Shen, Y., Xie, L., Chen, X., Mao, L., Qin, Y., Lan, R., Yang, S., Hu, J., Li, X., and Ye, H. (2022). Renal Fat Fraction Is Significantly Associated with the Risk of Chronic Kidney Disease in Patients with Type 2 Diabetes. Front. Endocrinol., 13.","DOI":"10.3389\/fendo.2022.995028"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"104367","DOI":"10.1016\/j.numecd.2025.104367","article-title":"Stratified CT Analysis of Renal, Perirenal and Renal Sinus Fat in Type 2 Diabetes Mellitus and Diabetic Kidney Disease","volume":"36","author":"Peng","year":"2026","journal-title":"Nutr. Metab. Cardiovasc. Dis."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"2322","DOI":"10.2337\/db20-1031","article-title":"Perirenal Fat Thickness Is Significantly Associated with the Risk for Development of Chronic Kidney Disease in Patients with Diabetes","volume":"70","author":"Chen","year":"2021","journal-title":"Diabetes"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1161\/HYPERTENSIONAHA.110.157370","article-title":"Renal Sinus Fat and Poor Blood Pressure Control in Middle-Aged and Elderly Individuals at Risk for Cardiovascular Events","volume":"56","author":"Chughtai","year":"2010","journal-title":"Hypertension"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.orcp.2024.03.005","article-title":"Renal Sinus Fat Is Associated with Intrarenal Hemodynamic Abnormalities Independent of Visceral Fat in Patients with Chronic Kidney Disease","volume":"18","author":"Kaneko","year":"2024","journal-title":"Obes. Res. Clin. Pract."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"527","DOI":"10.23876\/j.krcp.21.138","article-title":"Fructose in the Kidney: From Physiology to Pathology","volume":"40","author":"Nakagawa","year":"2021","journal-title":"Kidney Res. Clin. Pract."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"167074","DOI":"10.1016\/j.bbadis.2024.167074","article-title":"Fructose Overconsumption Accelerates Renal Dysfunction with Aberrant Glomerular Endothelial-Mesangial Cell Interactions in Db\/Db Mice","volume":"1870","author":"Tsuruta","year":"2024","journal-title":"Biochim. Biophys. Acta (BBA)\u2014Mol. Basis Dis."},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Bier, A., Shapira, E., Khasbab, R., Sharabi, Y., Grossman, E., and Leibowitz, A. (2022). High-Fructose Diet Increases Renal ChREBP\u03b2 Expression, Leading to Intrarenal Fat Accumulation in a Rat Model with Metabolic Syndrome. Biology, 11.","DOI":"10.3390\/biology11040618"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1038\/nm.3762","article-title":"Defective Fatty Acid Oxidation in Renal Tubular Epithelial Cells Has a Key Role in Kidney Fibrosis Development","volume":"21","author":"Kang","year":"2015","journal-title":"Nat. Med."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"e140695","DOI":"10.1172\/JCI140695","article-title":"Renal Tubule Cpt1a Overexpression Protects from Kidney Fibrosis by Restoring Mitochondrial Homeostasis","volume":"131","author":"Miguel","year":"2021","journal-title":"J. Clin. Investig."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1681\/ASN.2017070802","article-title":"Impairment of PPAR\u03b1 and the Fatty Acid Oxidation Pathway Aggravates Renal Fibrosis during Aging","volume":"29","author":"Chung","year":"2018","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"F618","DOI":"10.1152\/ajprenal.00309.2013","article-title":"Proximal Tubule PPAR\u03b1 Attenuates Renal Fibrosis and Inflammation Caused by Unilateral Ureteral Obstruction","volume":"305","author":"Li","year":"2013","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1038\/s41419-022-04515-3","article-title":"STAT6 Contributes to Renal Fibrosis by Modulating PPAR\u03b1-Mediated Tubular Fatty Acid Oxidation","volume":"13","author":"Li","year":"2022","journal-title":"Cell Death Dis."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"e179362","DOI":"10.1172\/jci.insight.179362","article-title":"Involvement of Impaired Carnitine-Induced Fatty Acid Oxidation in Experimental and Human Diabetic Kidney Disease","volume":"10","author":"Ito","year":"2025","journal-title":"JCI Insight"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1038\/5030","article-title":"Primary Systemic Carnitine Deficiency Is Caused by Mutations in a Gene Encoding Sodium Ion-Dependent Carnitine Transporter","volume":"21","author":"Nezu","year":"1999","journal-title":"Nat. Genet."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"2247","DOI":"10.1093\/hmg\/8.12.2247","article-title":"Genetic Epidemiology of the Carnitine Transporter OCTN2 Gene in a Japanese Population and Phenotypic Characterization in Japanese Pedigrees with Primary Systemic Carnitine Deficiency","volume":"8","author":"Koizumi","year":"1999","journal-title":"Hum. Mol. Genet."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.kint.2024.02.025","article-title":"The Key Role of Altered Tubule Cell Lipid Metabolism in Kidney Disease Development","volume":"106","author":"Lee","year":"2024","journal-title":"Kidney Int."},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Hadjivasilis, A., Kouis, P., Kousios, A., and Panayiotou, A. (2022). The Effect of Fibrates on Kidney Function and Chronic Kidney Disease Progression: A Systematic Review and Meta-Analysis of Randomised Studies. J. Clin. Med., 11.","DOI":"10.3390\/jcm11030768"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1038\/s41420-025-02419-7","article-title":"High-Fat Diet Promotes Lipotoxicity in the Podocytes of Uninephrectomized Mice: A Targeted Lipidomics and Kidney Podocyte-Specific Analysis","volume":"11","author":"Oh","year":"2025","journal-title":"Cell Death Discov."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1016\/j.kint.2020.06.040","article-title":"Sterol-O-Acyltransferase-1 Has a Role in Kidney Disease Associated with Diabetes and Alport Syndrome","volume":"98","author":"Liu","year":"2020","journal-title":"Kidney Int."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"e114","DOI":"10.2337\/dc10-0596","article-title":"Pro12Ala Polymorphism in the PPARG Gene Contributes to the Development of Diabetic Nephropathy in Chinese Type 2 Diabetic Patients: Comment on the Study by Liu et al","volume":"33","author":"Lapice","year":"2010","journal-title":"Diabetes Care"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"4011","DOI":"10.1093\/ndt\/gfr187","article-title":"PPAR\u03b32 P12A Polymorphism and Albuminuria in Patients with Type 2 Diabetes: A Meta-Analysis of Case\u2013Control Studies","volume":"26","author":"Prudente","year":"2011","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.ebiom.2018.10.072","article-title":"PPAR\u03b3 Maintains the Metabolic Heterogeneity and Homeostasis of Renal Tubules","volume":"38","author":"Lyu","year":"2018","journal-title":"eBioMedicine"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"2292753","DOI":"10.1080\/0886022X.2023.2292753","article-title":"CD36 Deletion Ameliorates Diabetic Kidney Disease by Restoring Fatty Acid Oxidation and Improving Mitochondrial Function","volume":"45","author":"Niu","year":"2023","journal-title":"Ren. Fail."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"e172963","DOI":"10.1172\/JCI172963","article-title":"ACSS2 Gene Variants Determine Kidney Disease Risk by Controlling de Novo Lipogenesis in Kidney Tubules","volume":"134","author":"Mukhi","year":"2024","journal-title":"J. Clin. Investig."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"3200","DOI":"10.1038\/s41467-024-47315-3","article-title":"Inhibition of ACSS2-Mediated Histone Crotonylation Alleviates Kidney Fibrosis via IL-1\u03b2-Dependent Macrophage Activation and Tubular Cell Senescence","volume":"15","author":"Li","year":"2024","journal-title":"Nat. Commun."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"e165817","DOI":"10.1172\/jci.insight.165817","article-title":"Activation of Acetyl-CoA Synthetase 2 Mediates Kidney Injury in Diabetic Nephropathy","volume":"8","author":"Lu","year":"2023","journal-title":"JCI Insight"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"155724","DOI":"10.1016\/j.metabol.2023.155724","article-title":"CCDC92 Deficiency Ameliorates Podocyte Lipotoxicity in Diabetic Kidney Disease","volume":"150","author":"Zuo","year":"2024","journal-title":"Metabolism"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1038\/s41401-023-01213-4","article-title":"CCDC92 Promotes Podocyte Injury by Regulating PA28\u03b1\/ABCA1\/Cholesterol Efflux Axis in Type 2 Diabetic Mice","volume":"45","author":"Zuo","year":"2024","journal-title":"Acta Pharmacol. Sin."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"114075","DOI":"10.1016\/j.celrep.2024.114075","article-title":"Genetic or Pharmacologic Blockade of mPGES-2 Attenuates Renal Lipotoxicity and Diabetic Kidney Disease by Targeting Rev-Erb\u03b1\/FABP5 Signaling","volume":"43","author":"Zhong","year":"2024","journal-title":"Cell Rep."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1038\/s41419-023-06236-7","article-title":"Targeting mPGES-2 to Protect against Acute Kidney Injury via Inhibition of Ferroptosis Dependent on P53","volume":"14","author":"Zhong","year":"2023","journal-title":"Cell Death Dis."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1038\/s41581-020-0309-2","article-title":"Autophagy in Kidney Homeostasis and Disease","volume":"16","author":"Tang","year":"2020","journal-title":"Nat. Rev. Nephrol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1038\/s41419-019-2002-6","article-title":"Lysosome Restoration to Activate Podocyte Autophagy: A New Therapeutic Strategy for Diabetic Kidney Disease","volume":"10","author":"Liu","year":"2019","journal-title":"Cell Death Dis."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"8643","DOI":"10.1038\/s41598-017-07889-z","article-title":"Blockage of the Lysosome-Dependent Autophagic Pathway Contributes to Complement Membrane Attack Complex-Induced Podocyte Injury in Idiopathic Membranous Nephropathy","volume":"7","author":"Liu","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1172\/JCI39492","article-title":"Autophagy Influences Glomerular Disease Susceptibility and Maintains Podocyte Homeostasis in Aging Mice","volume":"120","author":"Hartleben","year":"2010","journal-title":"J. Clin. Investig."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1038\/nature17184","article-title":"PGC1\u03b1 Drives NAD Biosynthesis Linking Oxidative Metabolism to Renal Protection","volume":"531","author":"Tran","year":"2016","journal-title":"Nature"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"e181443","DOI":"10.1172\/jci.insight.181443","article-title":"NAD+ Prevents Chronic Kidney Disease by Activating Renal Tubular Metabolism","volume":"10","author":"Jones","year":"2025","journal-title":"JCI Insight"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"100610","DOI":"10.1016\/j.jlr.2024.100610","article-title":"Dyslipidemia-Induced Renal Fibrosis Related to Ferroptosis and Endoplasmic Reticulum Stress","volume":"65","author":"Jiang","year":"2024","journal-title":"J. Lipid Res."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1038\/s12276-025-01406-3","article-title":"ACOT12, a Novel Factor in the Pathogenesis of Kidney Fibrosis, Modulates ACBD5","volume":"57","author":"Kim","year":"2025","journal-title":"Exp. Mol. Med."},{"key":"ref_57","doi-asserted-by":"crossref","unstructured":"Burgy, O., Loriod, S., Beltramo, G., and Bonniaud, P. (2022). Extracellular Lipids in the Lung and Their Role in Pulmonary Fibrosis. Cells, 11.","DOI":"10.3390\/cells11071209"},{"key":"ref_58","doi-asserted-by":"crossref","unstructured":"Suryadevara, V., Ramchandran, R., Kamp, D.W., and Natarajan, V. (2020). Lipid Mediators Regulate Pulmonary Fibrosis: Potential Mechanisms and Signaling Pathways. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21124257"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1186\/s12944-024-02062-8","article-title":"The Novel Molecular Mechanism of Pulmonary Fibrosis: Insight into Lipid Metabolism from Reanalysis of Single-Cell RNA-Seq Databases","volume":"23","author":"Shi","year":"2024","journal-title":"Lipids Health Dis."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1186\/s12944-024-02108-x","article-title":"Updated Mechanisms of MASLD Pathogenesis","volume":"23","author":"Li","year":"2024","journal-title":"Lipids Health Dis."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"819","DOI":"10.2337\/db18-0090","article-title":"Proximal Tubular Cell\u2013Specific Ablation of Carnitine Acetyltransferase Causes Tubular Disease and Secondary Glomerulosclerosis","volume":"68","author":"Kruger","year":"2019","journal-title":"Diabetes"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"355","DOI":"10.34067\/KID.0004772020","article-title":"Proximal Tubular Oxidative Metabolism in Acute Kidney Injury and the Transition to CKD","volume":"2","author":"Schaub","year":"2021","journal-title":"Kidney360"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"F796","DOI":"10.1152\/ajprenal.00157.2025","article-title":"Regional Metabolic Analysis of Structurally Preserved Kidney Slices by Ex Vivo Respirometry","volume":"329","author":"Bessho","year":"2025","journal-title":"Am. J. Physiol.-Ren. Physiol."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1007\/s00018-026-06143-y","article-title":"BPGM Shapes NFAT5-Driven Cellular Responses","volume":"83","author":"Roegner","year":"2026","journal-title":"Cell. Mol. Life Sci."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"eadu3730","DOI":"10.1126\/sciadv.adu3730","article-title":"A Lipid Atlas of the Human Kidney","volume":"11","author":"Farrow","year":"2025","journal-title":"Sci. Adv."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"9364","DOI":"10.1021\/acs.analchem.1c00649","article-title":"High-Resolution Human Kidney Molecular Histology by Imaging Mass Spectrometry of Lipids","volume":"93","author":"Mosteiro","year":"2021","journal-title":"Anal. Chem."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/s00216-011-4802-0","article-title":"Imaging of Complex Sulfatides SM3 and SB1a in Mouse Kidney Using MALDI-TOF\/TOF Mass Spectrometry","volume":"401","author":"Marsching","year":"2011","journal-title":"Anal. Bioanal. Chem."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"2343","DOI":"10.1194\/jlr.M051821","article-title":"Quantitative Imaging Mass Spectrometry of Renal Sulfatides: Validation by Classical Mass Spectrometric Methods1","volume":"55","author":"Marsching","year":"2014","journal-title":"J. Lipid Res."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.ebiom.2016.03.033","article-title":"Mass Spectrometry Imaging Reveals Elevated Glomerular ATP\/AMP in Diabetes\/Obesity and Identifies Sphingomyelin as a Possible Mediator","volume":"7","author":"Miyamoto","year":"2016","journal-title":"eBioMedicine"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1194\/jlr.M049189","article-title":"Diabetic Nephropathy Induces Alterations in the Glomerular and Tubule Lipid Profiles","volume":"55","author":"Grove","year":"2014","journal-title":"J. Lipid Res."},{"key":"ref_71","doi-asserted-by":"crossref","unstructured":"Zhang, Y., Piao, H.-L., and Chen, D. (2024). Identification of Spatial Specific Lipid Metabolic Signatures in Long-Standing Diabetic Kidney Disease. Metabolites, 14.","DOI":"10.3390\/metabo14110641"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"100552","DOI":"10.1016\/j.jlr.2024.100552","article-title":"Association of Plasma Ceramide with Decline in Kidney Function in Patients with Type 2 Diabetes","volume":"65","author":"Gurung","year":"2024","journal-title":"J. Lipid Res."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"2803","DOI":"10.1021\/acs.jproteome.9b00108","article-title":"Alterations in Lipid Profile of the Aging Kidney Identified by MALDI Imaging Mass Spectrometry","volume":"18","author":"Noh","year":"2019","journal-title":"J. Proteome Res."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"F1136","DOI":"10.1152\/ajprenal.00100.2016","article-title":"Early Lipid Changes in Acute Kidney Injury Using SWATH Lipidomics Coupled with MALDI Tissue Imaging","volume":"310","author":"Rao","year":"2016","journal-title":"Am. J. Physiol.-Ren. Physiol."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"3575","DOI":"10.1021\/acs.analchem.8b05521","article-title":"Rapid Identification of Ischemic Injury in Renal Tissue by Mass-Spectrometry Imaging","volume":"91","author":"Ellis","year":"2019","journal-title":"Anal. Chem."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"117616","DOI":"10.1016\/j.cca.2023.117616","article-title":"Plasma Oxidative Lipidomics Reveals Signatures for Sepsis-Associated Acute Kidney Injury","volume":"551","author":"Zhou","year":"2023","journal-title":"Clin. Chim. Acta"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.talanta.2016.11.026","article-title":"MALDI-LTQ-Orbitrap Mass Spectrometry Imaging for Lipidomic Analysis in Kidney under Cisplatin Chemotherapy","volume":"164","author":"Humanes","year":"2017","journal-title":"Talanta"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1194\/jlr.M080465","article-title":"Lipid Imaging for Visualizing Cilastatin Amelioration of Cisplatin-Induced Nephrotoxicity","volume":"59","author":"Aboulmagd","year":"2018","journal-title":"J. Lipid Res."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1002\/lipd.12171","article-title":"Two Specific Sulfatide Species Are Dysregulated during Renal Development in a Mouse Model of Alport Syndrome","volume":"54","author":"Gessel","year":"2019","journal-title":"Lipids"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1681\/ASN.2014050508","article-title":"Renal Glycosphingolipid Metabolism Is Dysfunctional in Lupus Nephritis","volume":"26","author":"Nowling","year":"2015","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1007\/s00216-014-8402-7","article-title":"Fabry Disease: Renal Sphingolipid Distribution in the \u03b1-Gal A Knockout Mouse Model by Mass Spectrometric and Immunohistochemical Imaging","volume":"407","author":"Kuchar","year":"2015","journal-title":"Anal. Bioanal. Chem."},{"key":"ref_82","doi-asserted-by":"crossref","unstructured":"Zhu, X., Jiang, L., Long, M., Wei, X., Hou, Y., and Du, Y. (2021). Metabolic Reprogramming and Renal Fibrosis. Front. Med., 8.","DOI":"10.3389\/fmed.2021.746920"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1038\/nrneph.2017.107","article-title":"Mitochondrial Energetics in the Kidney","volume":"13","author":"Bhargava","year":"2017","journal-title":"Nat. Rev. Nephrol."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"107105","DOI":"10.1016\/j.phrs.2024.107105","article-title":"ACOX1 Deficiency-Induced Lipid Metabolic Disorder Facilitates Chronic Interstitial Fibrosis Development in Renal Allografts","volume":"201","author":"Zhang","year":"2024","journal-title":"Pharmacol. Res."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1038\/s41419-019-2218-5","article-title":"Drp1-Mediated Mitochondrial Fission Promotes Renal Fibroblast Activation and Fibrogenesis","volume":"11","author":"Wang","year":"2020","journal-title":"Cell Death Dis."},{"key":"ref_86","doi-asserted-by":"crossref","unstructured":"Cao, Y., Chen, Z., Hu, J., Feng, J., Zhu, Z., Fan, Y., Lin, Q., and Ding, G. (2021). Mfn2 Regulates High Glucose-Induced MAMs Dysfunction and Apoptosis in Podocytes via PERK Pathway. Front. Cell Dev. Biol., 9.","DOI":"10.3389\/fcell.2021.769213"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"17257","DOI":"10.1038\/s41598-023-44538-0","article-title":"Increased Ca2+ Transport across the Mitochondria-Associated Membranes by Mfn2 Inhibiting Endoplasmic Reticulum Stress in Ischemia\/Reperfusion Kidney Injury","volume":"13","author":"Wang","year":"2023","journal-title":"Sci. Rep."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/j.cmet.2019.08.003","article-title":"Mitochondrial Damage and Activation of the STING Pathway Lead to Renal Inflammation and Fibrosis","volume":"30","author":"Chung","year":"2019","journal-title":"Cell Metab."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.kint.2020.10.013","article-title":"Kidney Epithelial Targeted Mitochondrial Transcription Factor A Deficiency Results in Progressive Mitochondrial Depletion Associated with Severe Cystic Disease","volume":"99","author":"Ishii","year":"2021","journal-title":"Kidney Int."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"4026","DOI":"10.7150\/ijbs.73493","article-title":"AKAP1 Contributes to Impaired mtDNA Replication and Mitochondrial Dysfunction in Podocytes of Diabetic Kidney Disease","volume":"18","author":"Feng","year":"2022","journal-title":"Int. J. Biol. Sci."},{"key":"ref_91","doi-asserted-by":"crossref","unstructured":"Juszczak, F., Arnould, T., and Decl\u00e8ves, A.-E. (2024). The Role of Mitochondrial Sirtuins (SIRT3, SIRT4 and SIRT5) in Renal Cell Metabolism: Implication for Kidney Diseases. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms25136936"},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1038\/s41419-018-1057-0","article-title":"SIRT3 Deficiency Leads to Induction of Abnormal Glycolysis in Diabetic Kidney with Fibrosis","volume":"9","author":"Srivastava","year":"2018","journal-title":"Cell Death Dis."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"F561","DOI":"10.1152\/ajprenal.00036.2017","article-title":"Inhibiting Aerobic Glycolysis Suppresses Renal Interstitial Fibroblast Activation and Renal Fibrosis","volume":"313","author":"Ding","year":"2017","journal-title":"Am. J. Physiol.-Ren. Physiol."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"2004","DOI":"10.1681\/ASN.2010121249","article-title":"Hypoxia-Inducible Transcription Factors Stabilization in the Thick Ascending Limb Protects against Ischemic Acute Kidney Injury","volume":"22","author":"Schley","year":"2011","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"3356","DOI":"10.1681\/ASN.2015020177","article-title":"Mitochondrial Pathology and Glycolytic Shift during Proximal Tubule Atrophy after Ischemic AKI","volume":"27","author":"Lan","year":"2016","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"2411943","DOI":"10.1002\/advs.202411943","article-title":"Aldehyde Dehydrogenase 2 Lactylation Aggravates Mitochondrial Dysfunction by Disrupting PHB2 Mediated Mitophagy in Acute Kidney Injury","volume":"12","author":"Li","year":"2025","journal-title":"Adv. Sci."},{"key":"ref_97","doi-asserted-by":"crossref","unstructured":"Xu, J., Zhou, L., and Liu, Y. (2020). Cellular Senescence in Kidney Fibrosis: Pathologic Significance and Therapeutic Strategies. Front. Pharmacol., 11.","DOI":"10.3389\/fphar.2020.601325"},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1038\/nm.2144","article-title":"Epithelial Cell Cycle Arrest in G2\/M Mediates Kidney Fibrosis after Injury","volume":"16","author":"Yang","year":"2010","journal-title":"Nat. Med."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"eabb0203","DOI":"10.1126\/scitranslmed.abb0203","article-title":"Cellular Senescence Inhibits Renal Regeneration after Injury in Mice, with Senolytic Treatment Promoting Repair","volume":"13","author":"Mylonas","year":"2021","journal-title":"Sci. Transl. Med."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1681\/ASN.2014111059","article-title":"Autophagy Induces Prosenescent Changes in Proximal Tubular S3 Segments","volume":"27","author":"Baisantry","year":"2016","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1080\/15548627.2022.2072054","article-title":"Tubular Cells Produce FGF2 via Autophagy after Acute Kidney Injury Leading to Fibroblast Activation and Renal Fibrosis","volume":"19","author":"Livingston","year":"2023","journal-title":"Autophagy"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1038\/s41419-023-06093-4","article-title":"Plk1 Promotes Renal Tubulointerstitial Fibrosis by Targeting Autophagy\/Lysosome Axis","volume":"14","author":"Du","year":"2023","journal-title":"Cell Death Dis."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1016\/j.kint.2026.01.028","article-title":"Increased Smoothened Signaling Promotes Kidney Fibrosis through Inhibiting Autophagy in Fibroblasts","volume":"109","author":"Wang","year":"2026","journal-title":"Kidney Int."},{"key":"ref_104","doi-asserted-by":"crossref","unstructured":"Li, L., Ye, Z., Xia, Y., Li, B., Chen, L., Yan, X., Yuan, T., Song, B., Yu, W., and Rao, T. (2023). YAP\/ACSL4 Pathway-Mediated Ferroptosis Promotes Renal Fibrosis in the Presence of Kidney Stones. Biomedicines, 11.","DOI":"10.2139\/ssrn.4509023"},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"102262","DOI":"10.1016\/j.redox.2022.102262","article-title":"ACSL4 Deficiency Confers Protection against Ferroptosis-Mediated Acute Kidney Injury","volume":"51","author":"Wang","year":"2022","journal-title":"Redox Biol."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1038\/s41420-022-00931-8","article-title":"Ferroptosis, a New Target for Treatment of Renal Injury and Fibrosis in a 5\/6 Nephrectomy-Induced CKD Rat Model","volume":"8","author":"Wang","year":"2022","journal-title":"Cell Death Discov."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1159\/000517723","article-title":"Targeting Ferroptosis Attenuates Interstitial Inflammation and Kidney Fibrosis","volume":"8","author":"Zhou","year":"2022","journal-title":"Kidney Dis."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"C619","DOI":"10.1152\/ajpcell.00660.2025","article-title":"Targeting Activated Kidney Fibroblasts via Ferroptosis: A Potential Antifibrotic Strategy","volume":"330","author":"Song","year":"2026","journal-title":"Am. J. Physiol.-Cell Physiol."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"F1355","DOI":"10.1152\/ajprenal.00003.2007","article-title":"Leptin Is a Coactivator of TGF-\u03b2 in Unilateral Ureteral Obstructive Kidney Disease","volume":"293","author":"Gueler","year":"2007","journal-title":"Am. J. Physiol.\u2014Ren. Physiol."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"F871","DOI":"10.1152\/ajprenal.00209.2013","article-title":"Thrombospondin 1 Mediates Renal Dysfunction in a Mouse Model of High-Fat Diet-Induced Obesity","volume":"305","author":"Cui","year":"2013","journal-title":"Am. J. Physiol.-Ren. Physiol."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1007\/s10157-020-01944-2","article-title":"AdipoRon, an Adiponectin Receptor Agonist, Protects Contrast-Induced Nephropathy by Suppressing Oxidative Stress and Inflammation via Activation of the AMPK Pathway","volume":"24","author":"Gu","year":"2020","journal-title":"Clin. Exp. Nephrol."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"F558","DOI":"10.1152\/ajprenal.00137.2018","article-title":"Adiponectin Attenuates Kidney Injury and Fibrosis in Deoxycorticosterone Acetate-Salt and Angiotensin II-Induced CKD Mice","volume":"315","author":"Tian","year":"2018","journal-title":"Am. J. Physiol.-Ren. Physiol."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"F1366","DOI":"10.1152\/ajprenal.00137.2012","article-title":"Adiponectin Attenuates Angiotensin II-Induced Oxidative Stress in Renal Tubular Cells through AMPK and cAMP-Epac Signal Transduction Pathways","volume":"304","author":"Fang","year":"2013","journal-title":"Am. J. Physiol.-Ren. Physiol."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s10334-019-00773-z","article-title":"Renal Sinus Fat and Renal Hemodynamics: A Cross-Sectional Analysis","volume":"33","author":"Spit","year":"2020","journal-title":"Magn. Reson. Mater. Phy."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1016\/j.metabol.2009.01.013","article-title":"Circulating Angiotensin II Is Associated with Body Fat Accumulation and Insulin Resistance in Obese Subjects with Type 2 Diabetes Mellitus","volume":"58","author":"Saiki","year":"2009","journal-title":"Metabolism"},{"key":"ref_116","first-page":"3925","article-title":"Human Adipose Tissue Expresses Angiotensinogen and Enzymes Required for Its Conversion to Angiotensin II","volume":"83","author":"Karlsson","year":"1998","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1210\/en.2008-1120","article-title":"Deficiency of Angiotensin Type 2 Receptor Rescues Obesity But Not Hypertension Induced by Overexpression of Angiotensinogen in Adipose Tissue","volume":"150","author":"Ailhaud","year":"2009","journal-title":"Endocrinology"},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"3244","DOI":"10.1038\/s41440-025-02401-x","article-title":"Effects of Perirenal Fat Accumulation on Cardiometabolic and Renal Functions and Mineralocorticoid Receptor Activation in Primary Aldosteronism","volume":"48","author":"Mitsuno","year":"2025","journal-title":"Hypertens. Res."},{"key":"ref_119","doi-asserted-by":"crossref","unstructured":"Thieme, K., and Oliveira-Souza, M. (2015). Renal Hemodynamic and Morphological Changes after 7 and 28 Days of Leptin Treatment: The Participation of Angiotensin II via the AT1 Receptor. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0122265"},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1080\/03008207.2018.1500558","article-title":"Oncostatin M and Its Role in Fibrosis","volume":"60","author":"Stawski","year":"2019","journal-title":"Connect. Tissue Res."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1007\/s10142-025-01624-y","article-title":"Functional Genomics Reveals Adipose-Kidney Crosstalk as a Contributor to Kidney Fibrosis via the OSM-OSMR Pathway","volume":"25","author":"Zhang","year":"2025","journal-title":"Funct. Integr. Genom."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1038\/s41366-026-02033-2","article-title":"Adipocyte Extracellular Vesicles (AdEVs) Promote a Proinflammatory and Profibrotic Profile in Human Renal and Endothelial Cells In Vitro","volume":"50","author":"Vecchiola","year":"2026","journal-title":"Int. J. Obes."},{"key":"ref_123","doi-asserted-by":"crossref","unstructured":"Eirin, A., Meng, Y., Zhu, X.-Y., Li, Y., Saadiq, I.M., Jordan, K.L., Tang, H., Lerman, A., Van Wijnen, A.J., and Lerman, L.O. (2021). The Micro-RNA Cargo of Extracellular Vesicles Released by Human Adipose Tissue-Derived Mesenchymal Stem Cells Is Modified by Obesity. Front. Cell Dev. Biol., 9.","DOI":"10.3389\/fcell.2021.660851"},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.ejphar.2017.12.016","article-title":"Inflammation and Renal Fibrosis: Recent Developments on Key Signaling Molecules as Potential Therapeutic Targets","volume":"820","author":"Lv","year":"2018","journal-title":"Eur. J. Pharmacol."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1038\/s41392-023-01379-7","article-title":"Kidney Fibrosis: From Mechanisms to Therapeutic Medicines","volume":"8","author":"Huang","year":"2023","journal-title":"Sig. Transduct. Target. Ther."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"155450","DOI":"10.1016\/j.phymed.2024.155450","article-title":"Shen-Shuai-II-Recipe Inhibits Tubular Inflammation by PPAR\u03b1-Mediated Fatty Acid Oxidation to Attenuate Fibroblast Activation in Fibrotic Kidneys","volume":"126","author":"Wang","year":"2024","journal-title":"Phytomedicine"},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1186\/s10020-024-00994-6","article-title":"FUT8 Upregulates CD36 and Its Core Fucosylation to Accelerate Pericyte-Myofibroblast Transition through the Mitochondrial-Dependent Apoptosis Pathway during AKI-CKD","volume":"30","author":"Shang","year":"2024","journal-title":"Mol. Med."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1038\/nm.3218","article-title":"Origin and Function of Myofibroblasts in Kidney Fibrosis","volume":"19","author":"LeBleu","year":"2013","journal-title":"Nat. Med."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"2282","DOI":"10.1681\/ASN.2008050513","article-title":"Fibroblasts in Kidney Fibrosis Emerge via Endothelial-to-Mesenchymal Transition","volume":"19","author":"Zeisberg","year":"2008","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"e2495","DOI":"10.1038\/cddis.2016.402","article-title":"Inflammatory Macrophages Can Transdifferentiate into Myofibroblasts during Renal Fibrosis","volume":"7","author":"Meng","year":"2016","journal-title":"Cell Death Dis."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"85","DOI":"10.2353\/ajpath.2010.090517","article-title":"Fate Tracing Reveals the Pericyte and Not Epithelial Origin of Myofibroblasts in Kidney Fibrosis","volume":"176","author":"Humphreys","year":"2010","journal-title":"Am. J. Pathol."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.ajpath.2012.09.009","article-title":"Transforming Growth Factor \u03b2-1 Stimulates Profibrotic Epithelial Signaling to Activate Pericyte-Myofibroblast Transition in Obstructive Kidney Fibrosis","volume":"182","author":"Wu","year":"2013","journal-title":"Am. J. Pathol."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"e11021","DOI":"10.15252\/emmm.201911021","article-title":"Dysregulated Mesenchymal PDGFR-\u03b2 Drives Kidney Fibrosis","volume":"12","author":"Buhl","year":"2020","journal-title":"EMBO Mol. Med."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1038\/s41467-025-67373-5","article-title":"Tracing the Origin of Myofibroblasts in Kidney Fibrosis","volume":"17","author":"He","year":"2025","journal-title":"Nat. Commun."},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1056\/NEJMoa2024816","article-title":"Dapagliflozin in Patients with Chronic Kidney Disease","volume":"383","author":"Heerspink","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"ref_136","doi-asserted-by":"crossref","unstructured":"The EMPA-KIDNEY Collaborative Group (2023). Empagliflozin in Patients with Chronic Kidney Disease. N. Engl. J. Med., 388, 117\u2013127.","DOI":"10.1056\/NEJMoa2204233"},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"106667","DOI":"10.1016\/j.phrs.2023.106667","article-title":"Neutral Effect of SGLT2 Inhibitors on Lipoprotein Metabolism: From Clinical Evidence to Molecular Mechanisms","volume":"188","author":"Osto","year":"2023","journal-title":"Pharmacol. Res."},{"key":"ref_138","doi-asserted-by":"crossref","unstructured":"Huang, C.-C., Chou, C.-A., Chen, W.-Y., Yang, J.-L., Lee, W.-C., Chen, J.-B., Lee, C.-T., and Li, L.-C. (2021). Empagliflozin Ameliorates Free Fatty Acid\u2013Induced Lipotoxicity in Renal Proximal Tubular Cells via the PPAR\u03b3\/CD36 Pathway in Obese Mice. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms222212408"},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"e164296","DOI":"10.1172\/jci.insight.164296","article-title":"Mapping the Metabolic Reprogramming Induced by Sodium-Glucose Cotransporter 2 Inhibition","volume":"8","author":"Riahi","year":"2023","journal-title":"JCI Insight"},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1038\/s41419-020-2544-7","article-title":"Sodium\u2013Glucose Cotransporter 2 Inhibition Suppresses HIF-1\u03b1-Mediated Metabolic Switch from Lipid Oxidation to Glycolysis in Kidney Tubule Cells of Diabetic Mice","volume":"11","author":"Cai","year":"2020","journal-title":"Cell Death Dis."},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1186\/s13098-023-01236-1","article-title":"Sodium-Dependent Glucose Transporter 2 Inhibitor Alleviates Renal Lipid Deposition and Improves Renal Oxygenation Levels in Newly Diagnosed Type 2 Diabetes Mellitus Patients: A Randomized Controlled Trial","volume":"15","author":"Zhang","year":"2023","journal-title":"Diabetol. Metab. Syndr."},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"e164486","DOI":"10.1172\/JCI164486","article-title":"SGLT2 Inhibitors Mitigate Kidney Tubular Metabolic and mTORC1 Perturbations in Youth-Onset Type 2 Diabetes","volume":"133","author":"Schaub","year":"2023","journal-title":"J. Clin. Investig."},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1056\/NEJMoa2403347","article-title":"Effects of Semaglutide on Chronic Kidney Disease in Patients with Type 2 Diabetes","volume":"391","author":"Perkovic","year":"2024","journal-title":"N. Engl. J. Med."},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"2058","DOI":"10.1111\/dom.14443","article-title":"Potential Kidney Protection with Liraglutide and Semaglutide: Exploratory Mediation Analysis","volume":"23","author":"Mann","year":"2021","journal-title":"Diabetes Obes. Metab."},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"e194749","DOI":"10.1172\/JCI194749","article-title":"GLP-1 Agonists in the Treatment of Chronic Kidney Disease in Type 2 Diabetes and Obesity","volume":"135","author":"Cooper","year":"2025","journal-title":"J. Clin. Investig."},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1053\/j.jrn.2020.09.006","article-title":"The Effect of Glycemic Control on Renal Triglyceride Content Assessed by Proton Spectroscopy in Patients With Type 2 Diabetes Mellitus: A Single-Center Parallel-Group Trial","volume":"31","author":"Dekkers","year":"2021","journal-title":"J. Ren. Nutr."},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"167060","DOI":"10.1016\/j.bbadis.2024.167060","article-title":"GLP-1 Receptor Agonist Attenuates Tubular Cell Ferroptosis in Diabetes via Enhancing AMPK-Fatty Acid Metabolism Pathway through Macropinocytosis","volume":"1870","author":"Shen","year":"2024","journal-title":"Biochim. Biophys. Acta (BBA)\u2014Mol. Basis Dis."},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"2409781","DOI":"10.1002\/advs.202409781","article-title":"GLP-1 Receptor Agonists Alleviate Diabetic Kidney Injury via \u03b2-Klotho-Mediated Ferroptosis Inhibition","volume":"12","author":"Tian","year":"2025","journal-title":"Adv. Sci."},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1056\/NEJMoa2025845","article-title":"Effect of Finerenone on Chronic Kidney Disease Outcomes in Type 2 Diabetes","volume":"383","author":"Bakris","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"2252","DOI":"10.1056\/NEJMoa2110956","article-title":"Cardiovascular Events with Finerenone in Kidney Disease and Type 2 Diabetes","volume":"385","author":"Pitt","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1093\/eurheartj\/ehab777","article-title":"Cardiovascular and Kidney Outcomes with Finerenone in Patients with Type 2 Diabetes and Chronic Kidney Disease: The FIDELITY Pooled Analysis","volume":"43","author":"Agarwal","year":"2022","journal-title":"Eur. Heart J."},{"key":"ref_152","doi-asserted-by":"crossref","unstructured":"Heerspink, H.J.L., Neuen, B.L., Agarwal, R., Cherney, D.Z.I., Lam, C.S.P., Tuttle, K.R., Wanner, C., Sarafidis, P., Jongs, N., and Smeijer, J.D. (2026). Finerenone in Persons with Chronic Kidney Disease without Diabetes. N. Engl. J. Med., NEJMoa2604625.","DOI":"10.1056\/NEJMoa2604625"},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"2685","DOI":"10.1161\/HYPERTENSIONAHA.122.19744","article-title":"Blood Pressure and Cardiorenal Outcomes with Finerenone in Chronic Kidney Disease in Type 2 Diabetes","volume":"79","author":"Ruilope","year":"2022","journal-title":"Hypertension"},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"3382","DOI":"10.1093\/eurheartj\/ehaf316","article-title":"Finerenone Effects on Biomarkers: An Analysis from the FIGARO-DKD Trial","volume":"46","author":"Berger","year":"2025","journal-title":"Eur. Heart J."},{"key":"ref_155","doi-asserted-by":"crossref","unstructured":"Zhai, S., Ma, B., Chen, W., and Zhao, Q. (2024). A Comprehensive Review of Finerenone\u2014A Third-Generation Non-Steroidal Mineralocorticoid Receptor Antagonist. Front. Cardiovasc. Med., 11.","DOI":"10.3389\/fcvm.2024.1476029"},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"F724","DOI":"10.1152\/ajprenal.00136.2025","article-title":"The Nonsteroidal MR Antagonist Finerenone Reverses Western Diet-Induced Kidney Disease by Regulating Mitochondrial and Lipid Metabolism and Inflammation","volume":"329","author":"Myakala","year":"2025","journal-title":"Am. J. Physiol.-Ren. Physiol."},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1056\/NEJMoa2410659","article-title":"Finerenone with Empagliflozin in Chronic Kidney Disease and Type 2 Diabetes","volume":"393","author":"Agarwal","year":"2025","journal-title":"N. Engl. J. Med."},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1681\/ASN.0000000000000186","article-title":"Finerenone Added to RAS\/SGLT2 Blockade for CKD in Alport Syndrome. Results of a Randomized Controlled Trial with Col4a3\u2212\/\u2212 Mice","volume":"34","author":"Zhu","year":"2023","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"2849","DOI":"10.1038\/s41591-024-03133-0","article-title":"Effects of Semaglutide with and without Concomitant SGLT2 Inhibitor Use in Participants with Type 2 Diabetes and Chronic Kidney Disease in the FLOW Trial","volume":"30","author":"Mann","year":"2024","journal-title":"Nat. Med."},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"100139","DOI":"10.1016\/j.lanprc.2026.100139","article-title":"Kidney Outcomes with GLP-1 Receptor Agonists in People with Type 2 Diabetes Already Receiving SGLT2 Inhibitors: A Target Trial Emulation Study Using UK Primary Care Data","volume":"2","author":"Jansz","year":"2026","journal-title":"Lancet Prim. Care"},{"key":"ref_161","doi-asserted-by":"crossref","unstructured":"Aomura, D., Harada, M., Yamada, Y., Nakajima, T., Hashimoto, K., Tanaka, N., and Kamijo, Y. (2021). Pemafibrate Protects against Fatty Acid-Induced Nephropathy by Maintaining Renal Fatty Acid Metabolism. Metabolites, 11.","DOI":"10.3390\/metabo11060372"},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1056\/NEJMoa2210645","article-title":"Triglyceride Lowering with Pemafibrate to Reduce Cardiovascular Risk","volume":"387","author":"Glynn","year":"2022","journal-title":"N. Engl. J. Med."},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1159\/000529460","article-title":"IL-37 Ameliorates Renal Fibrosis by Restoring CPT1A-Mediated Fatty Acid Oxidation in Diabetic Kidney Disease","volume":"9","author":"Xiong","year":"2023","journal-title":"Kidney Dis."},{"key":"ref_164","doi-asserted-by":"crossref","first-page":"155162","DOI":"10.1016\/j.phymed.2023.155162","article-title":"Baicalin Ameliorates Renal Fibrosis by Upregulating CPT1\u03b1-Mediated Fatty Acid Oxidation in Diabetic Kidney Disease","volume":"122","author":"Hu","year":"2024","journal-title":"Phytomedicine"},{"key":"ref_165","doi-asserted-by":"crossref","first-page":"4662","DOI":"10.1038\/s41467-021-24890-3","article-title":"Compounds Targeting OSBPL7 Increase ABCA1-Dependent Cholesterol Efflux Preserving Kidney Function in Two Models of Kidney Disease","volume":"12","author":"Wright","year":"2021","journal-title":"Nat. Commun."},{"key":"ref_166","doi-asserted-by":"crossref","first-page":"F396","DOI":"10.1152\/ajprenal.00420.2018","article-title":"Prohibitin 2-Mediated Mitophagy Attenuates Renal Tubular Epithelial Cells Injury by Regulating Mitochondrial Dysfunction and NLRP3 Inflammasome Activation","volume":"316","author":"Xu","year":"2019","journal-title":"Am. J. Physiol.-Ren. Physiol."},{"key":"ref_167","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1080\/15548627.2025.2601874","article-title":"ESRRA-ATG5-Mediated Mitophagy Enhances Arginine Metabolism to Alleviate Diabetic Kidney Disease","volume":"22","author":"Hu","year":"2026","journal-title":"Autophagy"},{"key":"ref_168","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1016\/j.cell.2011.03.054","article-title":"Pyruvate Kinase M2 Is a PHD3-Stimulated Coactivator for Hypoxia-Inducible Factor 1","volume":"145","author":"Luo","year":"2011","journal-title":"Cell"},{"key":"ref_169","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1038\/nchembio.1060","article-title":"Pyruvate Kinase M2 Activators Promote Tetramer Formation and Suppress Tumorigenesis","volume":"8","author":"Anastasiou","year":"2012","journal-title":"Nat. Chem. Biol."},{"key":"ref_170","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1111\/jdi.13478","article-title":"The PKM2 Activator TEPP-46 Suppresses Kidney Fibrosis via Inhibition of the EMT Program and Aberrant Glycolysis Associated with Suppression of HIF-1\u03b1 Accumulation","volume":"12","author":"Liu","year":"2021","journal-title":"J. Diabetes Investig."},{"key":"ref_171","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1186\/s12951-026-04370-w","article-title":"Inhibiting Lactylation for Efficient Treatment of Renal Fibrosis through Targeting Nanomedicine of Renal Lactate Accumulation in Obstructed Kidney","volume":"24","author":"Zhao","year":"2026","journal-title":"J. Nanobiotechnol."},{"key":"ref_172","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1016\/j.ekir.2017.03.011","article-title":"A Phase 2, Double-Blind, Placebo-Controlled, Randomized Study of Fresolimumab in Patients With Steroid-Resistant Primary Focal Segmental Glomerulosclerosis","volume":"2","author":"Vincenti","year":"2017","journal-title":"Kidney Int. Rep."},{"key":"ref_173","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.12659\/MSM.909236","article-title":"Specific Inhibitor of Smad3 (SIS3) Attenuates Fibrosis, Apoptosis, and Inflammation in Unilateral Ureteral Obstruction Kidneys by Inhibition of Transforming Growth Factor \u03b2 (TGF-\u03b2)\/Smad3 Signaling","volume":"24","author":"Ji","year":"2018","journal-title":"Med. Sci. Monit."},{"key":"ref_174","doi-asserted-by":"crossref","first-page":"eaat2039","DOI":"10.1126\/scitranslmed.aat2039","article-title":"Long Noncoding RNA Lnc-TSI Inhibits Renal Fibrogenesis by Negatively Regulating the TGF-\u03b2\/Smad3 Pathway","volume":"10","author":"Wang","year":"2018","journal-title":"Sci. Transl. Med."},{"key":"ref_175","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/j.omtn.2022.04.002","article-title":"MicroRNA-10a\/b Inhibit TGF-\u03b2\/Smad-Induced Renal Fibrosis by Targeting TGF-\u03b2 Receptor 1 in Diabetic Kidney Disease","volume":"28","author":"Li","year":"2022","journal-title":"Mol. Ther.\u2014Nucleic Acids"}],"container-title":["Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2079-7737\/15\/13\/1021\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T04:12:26Z","timestamp":1783138346000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2079-7737\/15\/13\/1021"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,26]]},"references-count":175,"journal-issue":{"issue":"13","published-online":{"date-parts":[[2026,7]]}},"alternative-id":["biology15131021"],"URL":"https:\/\/doi.org\/10.3390\/biology15131021","relation":{},"ISSN":["2079-7737"],"issn-type":[{"value":"2079-7737","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,26]]}}}